Study S000616

An Open-label, Randomized, Parallel-group, Single-center Trial to Compare Pharmacokinetics of Dapiglutide After a Single Subcutaneous Dose of the Drug Product Concentrations 10 mg/mL or 25 mg/mL in Participants With Overweight or Obesity

ClinicalTrials.gov record

Registration

Registration: NCT06758583
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 30
Start: 2024-12-23
Primary completion: 2025-04-12
Lead sponsor: Zealand Pharma
Conditions: Overweight and Obesity
Interventions: DRUG:Dapiglutide 7.5 mg
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: EUDRACT_NUMBER:2024-516901-21

Registered primary outcomes

To compare pharmacokinetics of a single dose administration of 7.5 mg dapiglutide [Trial Day 1 to 28]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.